One-Pot Synthesis of Treprostinil Intermediate via Ortho-Lithiation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for synthesizing prostacyclin derivatives, such as Treprostinil, face inefficiencies and yield issues due to the presence of undesired regioisomers and the need for multiple synthetic steps, solvents, and cryogenic conditions.

Innovation Solution

A one-pot synthesis method involving the in-situ protection of aldehydes with phenyllithium or butyllithium, followed by ortho-lithiation, conversion to a cuprate, and allylation with allyl iodide at ambient temperature, which stabilizes the ortho-anion and promotes allylation, reducing the number of steps and improving yield and purity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional multi-step synthesis methods are used for prostacyclin derivatives, then the synthesis can be completed with standard procedures, but the process requires multiple steps, solvents, and cryogenic conditions leading to lower yield and productivity

Engineering Contradiction:
Improvesynthesis efficiencyVSAvoidsynthetic process complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent combines multiple synthetic steps (protection, lithiation, cuprate formation, and allylation) into a single one-pot operation. The aldehyde is protected in-situ by phenyllithium or butyllithium, followed by ortho-lithiation, conversion to cuprate, and allylation with allyl iodide all occurring in the same reaction vessel without isolation of intermediates, thereby simplifying the synthetic process and improving productivity

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The aldehyde protection occurs in-situ before the main transformation sequence. The phenyllithium or butyllithium serves dual purposes: protecting the aldehyde group and enabling subsequent ortho-lithiation. This preliminary protective action prevents side reactions and simplifies the overall process by eliminating separate protection steps

Inventive Principle:
Principle #10Preliminary action

2Manufacturing precision

If conventional synthesis methods are used, then standard procedures can be applied, but undesired regioisomers are formed reducing the chemical purity of the product

Engineering Contradiction:
Improvechemical purityVSAvoidregioisomer formation
Core Design Contradiction:
Manufacturing precisionVSObject-generated harmful factors

Solution Approach 1:

The patent achieves high regioselectivity by creating a localized reactive species (ortho-lithiated intermediate) with specific spatial orientation. The lithiation occurs preferentially at the ortho position relative to the protecting group, and the subsequent cuprate formation and allylation occur at this specific location, ensuring high chemical purity by preventing regioisomer formation

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The ortho-lithiated intermediate acts as a key intermediary species that directs the subsequent reactions. This intermediate, formed through controlled lithiation, serves as a precursor to the cuprate species which then undergoes allylation. The intermediary controls the regioselectivity of the transformation, preventing formation of undesired regioisomers

Inventive Principle:
Principle #24Intermediary (Mediator)

3Ease of operation

If conventional methods are used, then standard equipment can be employed, but cryogenic equipment and column chromatographic purifications are required increasing time and operational complexity

Engineering Contradiction:
Improveoperational simplicityVSAvoidpurification time
Core Design Contradiction:
Ease of operationVSLoss of time

Solution Approach 1:

The reaction system performs its own purification function through the high regioselectivity of the one-pot transformation. The ortho-lithiated intermediate and subsequent cuprate allylation proceed with such specificity that minimal purification is required. The method eliminates the need for time-consuming column chromatographic purifications as the reaction inherently produces the desired product with high purity

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent conducts the entire synthesis sequence at ambient temperature rather than requiring cryogenic conditions. This parameter change from low temperature to ambient temperature simplifies equipment requirements, eliminating the need for cryogenic equipment while maintaining high reaction efficiency and selectivity throughout the multi-step transformation

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method enhances the yield and chemical purity of the desired Formula I compound, eliminating the need for cryogenic equipment and column chromatographic purifications, while allowing for efficient synthesis of Treprostinil and other prostacyclin derivatives.

Implementation Method 1

contacting an aldehyde represented by Formula C with a compound selected from the group consisting of Ra—NH2, RaRbN—(CHR′)x—NHRa and R′—OH in the presence of an organolitium

Methodology Applied
Scientific EffectNucleophilic addition: Chemical Bonding

Implementation Method 2

contacting the product from step (a) with an organolithium to form an ortho-lithiated product which is contacted with copper cyanide to form a cuprate

Methodology Applied
Scientific EffectMetal-cyanide complexation: Chemical Bonding

Implementation Method 3

contacting the cuprate from step (b) with an allyl halide selected from the group consisting of allyl chloride, allyl bromide and allyl iodide to form a Formula A compound

Methodology Applied
Scientific EffectNucleophilic substitution: Chemical Bonding

Implementation Method 4

the hydrolysis of a Formula A compound may be accomplished by contact with water, aqueous mineral acid, or an aqueous solution of sodium sulfite

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Data Source

PatentUS10077225B2Synthesis of intermediate for treprostinil production
Publication Date: 2018.09.18 UNITED THERAPEUTICS CORP
  • US10077225B2 patent drawing
  • US10077225B2 patent drawing
  • US10077225B2 patent drawing

AI summary

The compound according to Formula I is an intermediate in the synthesis of prostacylin analogs. The present invention provides an efficient method for synthesizing a Formula I compound.